http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9984039

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase III|Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 237
issn 0140-6736
issueIdentifier 9787
pageRange 229-237
publicationName Lancet (London, England)
startingPage 229
bibliographicCitation Cohen CJ, Andrade-Villanueva J, Clotet B, Fourie J, Johnson MA, Ruxrungtham K, Wu H, Zorrilla C, Crauwels H, Rimsky LT, Vanveggel S, Boven K; THRIVE study group. Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial. Lancet. 2011 Jul 16;378(9787):229–37. doi: 10.1016/s0140-6736(11)60983-5. PMID: 21763935.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27c007ee4f6026c72d2fec397ca02b11
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb470469f9b650013e9b944c0c7ecf59
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ad6fa3656196900828424be6cf3fff4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6d73d144e0d11a66ca87efdc399dd85
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51fcc9b0923f254cdf3ebff092c55810
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05cf643ddddb0b1ba3aeeda239f983f2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97e15521d67a5c93704281cad0948153
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1dd4205119620163d7e2506e64d3234b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df0af654bd741470d496eab1ec5627e2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_064535f3e821e55f446c2a0c7f6a3d17
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab7c976b30d95ae5319f3166cce96aee
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b88b9c52215c28527c35197bb18a68f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7348-2352
date 2011-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1016/s0140-6736%2811%2960983-5
https://pubmed.ncbi.nlm.nih.gov/21763935
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5470
https://portal.issn.org/resource/ISSN/0140-6736
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial
discusses http://id.nlm.nih.gov/mesh/M0571031
http://id.nlm.nih.gov/mesh/M0018260
http://id.nlm.nih.gov/mesh/M0028255
http://id.nlm.nih.gov/mesh/M0005491
http://id.nlm.nih.gov/mesh/M0337569
http://id.nlm.nih.gov/mesh/M0254881
http://id.nlm.nih.gov/mesh/M0503898
http://id.nlm.nih.gov/mesh/M0482137
http://id.nlm.nih.gov/mesh/M0000347
http://id.nlm.nih.gov/mesh/M0014878
http://id.nlm.nih.gov/mesh/M0015066
http://id.nlm.nih.gov/mesh/M0258297
http://id.nlm.nih.gov/mesh/M0015075
http://id.nlm.nih.gov/mesh/M0028839
http://id.nlm.nih.gov/mesh/M0461882
http://id.nlm.nih.gov/mesh/M0000724
http://id.nlm.nih.gov/mesh/M0005997
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6451164
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.7.49
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6398764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441300
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7483

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246357805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128575040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129727356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127945305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129233080
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129722732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128324017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621

Total number of triples: 66.